Cargando…
Bioinformatics analysis reveals TSPAN1 as a candidate biomarker of progression and prognosis in pancreatic cancer
Pancreatic cancer (PCC) is a common malignant tumor of the digestive system that is resistant to traditional treatments and has an overall 5-year survival rate of <7%. Transcriptomics research provides reliable biomarkers for diagnosis, prognosis, and clinical precision treatment, as well as the...
Autores principales: | Ma, Chenhui, Cui, ZeLong, Wang, YiChao, Zhang, Lei, Wen, JunYe, Guo, HuaiBin, Li, Na, Zhang, WanXing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861625/ https://www.ncbi.nlm.nih.gov/pubmed/33188589 http://dx.doi.org/10.17305/bjbms.2020.5096 |
Ejemplares similares
-
Assessment of TSPAN Expression Profile and Their Role in the VSCC Prognosis
por: Ferreira, Kelly Pedrozo, et al.
Publicado: (2021) -
Expression of Tspan8 in Patients with Intrahepatic Cholangiocarcinoma and Its Relationship with Clinicopathological Features and Prognosis
por: Tan, Zhenhua, et al.
Publicado: (2021) -
Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma
por: Schäfer, Daniel, et al.
Publicado: (2021) -
TSPAN1, TMPRSS4, SDR16C5, and CTSE as Novel Panel for Pancreatic Cancer: A Bioinformatics Analysis and Experiments Validation
por: Ye, Hua, et al.
Publicado: (2021) -
Silencing Tspan1 inhibits migration and invasion, and induces the apoptosis of human pancreatic cancer cells
por: Tian, Jiaxun, et al.
Publicado: (2018)